Dr. Gillett And James O'Hara NP, discuss the Semaglutide and Tirzepatide. 00:00 Intro 01:46 Why might we suggest this? 05:20 Titration schedule06:28 Why they designed this study this way 12:04 Ai 15:35 Who should use GLP1s 17:33 Costs of GLP1s 23:35 Closing points Studies/References: ► https://www.epicresearch.org/articles/tirzepatide-and-injectable-semaglutide-correlated-with-greatest-weight-loss-among-glp-1-medications► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987449/For High-quality labs:► https://gilletthealth.com/order-lab-panels/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O’Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth#weightloss #podcast #aiAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Ver todos los episodios